Gotham Asset Management, LLC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1510387 NEW YORK, NY

Position in RYTM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$612,441

+$190,811 QoQ

Shares Held

5,516

+13.8% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#179

of 299 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Gotham Asset Management, LLC holds $433,918,027 across 48 Biotechnology names. RYTM ranks #31 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	719,545	$81,567,621
2	REGN	Regeneron Pharmaceuticals, Inc.	105,165	$65,574,584
3	HALO	Halozyme Therapeutics, Inc.	739,273	$57,862,897
4	EXEL	Exelixis, Inc.	892,663	$48,569,793
5	ROIV	Roivant Sciences Ltd.	1,349,465	$47,757,566
6	JAZZ	Jazz Pharmaceuticals plc	112,014	$26,992,013
7	RVMD	Revolution Medicines, Inc.	120,702	$22,605,070
8	ALNY	Alnylam Pharmaceuticals, Inc.	42,051	$12,658,612

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$612,441	5,516	+13.8%	Shares	Sole	2026-08-14
2026-03-31	$421,630	4,848	-0.1%	Shares	Sole	2026-05-15
2025-12-31	$519,251	4,851	-0.1%	Shares	Sole	2026-02-17
2025-09-30	$490,306	4,855	+0.1%	Shares	Sole	2025-11-14
2025-06-30	$306,534	4,851	+2.1%	Shares	Sole	2025-08-14
2025-03-31	$251,607	4,750	-30.0%	Shares	Sole	2025-05-15
2024-12-31	$379,880	6,786	-28.3%	Shares	Sole	2025-02-14
2024-09-30	$496,185	9,471	-25.0%	Shares	Sole	2024-11-14
2024-06-30	$518,464	12,627	+13.7%	Shares	Sole	2024-08-14
2024-03-31	$481,092	11,103	-39.9%	Shares	Sole	2024-05-15
2023-12-31	$849,203	18,473	+29.0%	Shares	Sole	2024-02-14
2023-09-30	$328,263	14,319	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.